Wuhan, China

Xian Zeng

This inventor holds 1 USPTO granted patent. Top assignee: Wuhan Ll Science and Technology Development Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xian Zeng. Retrieved from https://idiyas.com/inventor/xian-zeng-rxt633mr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xian Zeng: Innovator in Rock Inhibitor Technology

Introduction

Xian Zeng is a notable inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of rock inhibitors. His work focuses on creating compounds that exhibit beneficial properties for medical applications.

Latest Patents

Xian Zeng holds a patent for a rock inhibitor and its preparation method. The compound represented by formula (I) demonstrates ROCK inhibitory activity, which is crucial for various therapeutic applications. This compound is characterized by its good safety profile, metabolic stability, and a low risk of potential hepatotoxicity. Additionally, the preparation method is straightforward, making it easy to purify and enhancing its application prospects.

Career Highlights

Xian Zeng is associated with Wuhan Ll Science and Technology Development Co., Ltd., where he continues to innovate in the field of pharmaceutical research. His work has the potential to impact the development of new treatments and improve patient outcomes.

Collaborations

Xian Zeng collaborates with Jinping Li, contributing to advancements in their shared field of research. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Xian Zeng's contributions to the development of rock inhibitors highlight his role as a key innovator in pharmaceutical technology. His work not only showcases his expertise but also promises to advance medical science significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…